TrialInternational journal of oncology2015

Favorable effect of the combination of vinorelbine and dihydropyrimidine dehydrogenase‑inhibitory fluoropyrimidine in EGFR‑mutated lung adenocarcinoma: retrospective and in vitro studies.

Hiroki Izumi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.